The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Afanasyeva M.A.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

Budzinskaia M.V.

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

Pliukhova A.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Current understanding of pachychoroid spectrum diseases

Authors:

Afanasyeva M.A., Budzinskaia M.V., Pliukhova A.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2019;135(5‑2): 293‑298

DOI: 10.17116/oftalma2019135052293

Read: 494 times

Download PDF (RU)
Contact the author
Table of contents

CURRENT UNDERSTANDING OF PACHYCHOROID SPECTRUM DISEASES
CURRENT UNDERSTANDING OF PACHYCHOROID SPECTRUM DISEASES

To cite this article:

Afanasyeva MA, Budzinskaia MV, Pliukhova AA. Current understanding of pachychoroid spectrum diseases. Russian Annals of Ophthalmology. 2019;135(5‑2):293‑298. (In Russ.)
https://doi.org/10.17116/oftalma2019135052293

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Peri­papillary pachychoroid syndrome. Russian Annals of Ophthalmology. 2024;(6):138-144
Abstract:

Pachychoroid spectrum diseases (the prefix «pachy-» means «thick») were proposed as the term indicating an abnormal increase in choroidal thickness, dilatation of choroid vessels and other structural changes in choroid architecture. Pachychoroid spectrum diseases include central serous chorioretinopathy, polypoidal choroidal vasculopathy, pachychoroid pigment epitheliopathy, focal choroidal excavation, pachychoroid neovasculopathy, peripapillary pachychoroid syndrome. Studying the new group of diseases associated with pachychoroid phenotype is a topical task in modern ophthalmology. The emergence of new diagnostic methods such as OCT with angiography mode allows detailed study of this disease group, helps determine the prognosis and choose the tactic for management of these patients.

Keywords:

pachychoroid spectrum diseases
features of pachychoroid spectrum diseases

Authors:

Afanasyeva M.A.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

Budzinskaia M.V.

FGBU "Nauchno-issledovatel'skiĭ institut glaznykh bolezneĭ" RAMN, Moskva

Pliukhova A.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Close metadata

References:

  1. Gallego-Pinazo R, Dolz-Marco R, Freund KB. Pachychoroid. Choroidal Disordes. 2017;161-170. https://doi.org/10.1016/b978-0-12-805313-3.00010-7
  2. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc. 1987;84:799-845. https://doi.org/10.1097/00006982-198700720-00009
  3. Haimovici R, Koh S, Gagnon DR, et al. Risk factors for central serous chorioretinopathy: A case-control study. Ophthalmology. 2004;11:244-249. https://doi.org/10.1016/j.ophtha.2003.09.024
  4. Eom Y, Oh J, Kim SW, Huh K. Systemic factors associated with central serous chorioretinopathy in Koreans. Korean J Ophthalmol. 2012;26(4):260-264. https://doi.org/10.3341/kjo.2012.26.4.260
  5. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 1992;2:103-114. https://doi.org/10.1177/112067219200200301
  6. Coscas G (ed): Macular Edema. 2nd, revised and extended edition. Dev Ophthalmol Basel, Karger. 2017;58:27-38. https://doi.org/10.1159/000455267
  7. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554-1572. https://doi.org/10.1016/s0161-6420(84)34117-3
  8. Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. 2002;22:19-24. https://doi.org/10.1097/00006982-200202000-00004
  9. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103:2070-2079; discussion 2079-2080. https://doi.org/10.1016/s0161-6420(96)30386-2
  10. Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol. 2003;87:709-712. https://doi.org/10.1136/bjo.87.6.709
  11. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina. 1994;14:231-242. https://doi.org/10.1097/00006982-199414030-00008
  12. Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina. 2010;30:801-809. https://doi.org/10.1097/iae.0b013e3181c72068
  13. Abouammoh MA. Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol. 2015;29(4):278-286. https://doi.org/10.1016/j.sjopt.2015.01.007
  14. Dansingani KK, Gal-Or O, Sadda SR, Yannuzzi LA, Freund KB. Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’ — a review. Clin Exp Ophthalmol. 2017;46(2):189-200. https://doi.org/10.1111/ceo.13114
  15. Honda S, Matsumiya W, Negi A. Polypoidal Choroidal Vasculopathy. Clinical Features and Genetic Predisposition. Ophthalmologica. 2014;231:59-74. https://doi.org/10.1159/000355488
  16. Jonas JB, Wei WB, Xu L, Wang YX. Systemic inflammation and eye diseases. The Beijing Eye Study. PLoS One. 2018;13(10):e0204263. https://doi.org/10.1371/journal.pone.0204263
  17. Kawamura A, Yuzawa M, Mori R, Haruyama M, Tanaka K. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmologica. 2013;91:474-481. https://doi.org/10.1111/aos.12110
  18. Honda S, Kurimoto Y, Kagotani Y, Yamamoto H, Takagi H, Uenishi M. Photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a 30-month multicenter study in Hyogo, Japan. Jpn J Ophthalmol. 2009;53:593-597. https://doi.org/10.1007/s10384-009-0741-0
  19. Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK; EVEREST II study group. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial. JAMA Ophthalmol. 2017;135(11):1206-1213. https://doi.org/10.1001/jamaophthalmol.2017.4030
  20. Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, Cheung GCM, Zhang Z, Leal S, Ishibashi I, PLANET Investigators. Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial. JAMA Ophthalmol. 2018;136(7):786-793. https://doi.org/10.1001/jamaophthalmol.2018.1804
  21. Chung H, Byeon SH, Freund B. Focal choroidal excavation and its association with pachychoroid spectrum disorders. Retina. 2017;37:199-221. https://doi.org/10.1097/iae.0000000000001345
  22. Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33:1659-1672. https://doi.org/10.1097/IAE.0b013e3182953df4
  23. Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35:1-9. https://doi.org/10.1097/iae.0000000000000331
  24. Phasukkijwatana, Nopasak Freund, K Bailey, Dolz-Marco, Rosa, Al-Sheikh, Mayss, Keane, Pearse A, Egan, Catherine A, Randhawa, Sandeep, Stewart, Jay M, Liu, Qingyun, Hunyor, Alex P, Kreiger, Allan, Nagiel, Aaron, Lalane, Robert, Rahimi, Mansour, Lee, Won Ki, Jampol, Lee Merrill, Sarraf, David. Peripapillary pachychoroid syndrome. Retina. 2018;38(9):1652-1667. https://doi.org/10.1097/iae.0000000000001907
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.